Monday, 23 November 2020 AstraZeneca announced Monday that positive high-level results from an interim analysis of clinical trials of the COVID-19 vaccine candidate in the UK and Brazil showed it was highly effective in preventing the disease, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants...
An FDA advisory committee will meet next month to discuss an emergency use authorization.
The emergency use authorization would be for Pfizer's COVID-19 vaccine.
Earlier this week, Pfizer said..
Delhi's annual wave of air pollution has coincided with the Covid-19 pandemic this year. Speaking at the Hindustan Times Leadership Summit 2020, Chief Minister Arvind Kejriwal said that pollution..
Credit: HT Digital Content Duration: 05:11Published
With Tennessee officials saying widespread distribution of a COVID-19 vaccine is still several months away, we are taking a closer look at the plan in place to distribute the vaccine in Tennessee.
The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 shot, aiming to have 100 million doses ready by December for an... IndiaTimes
AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental... Mid-Day
AstraZeneca said on Monday that late-stage trials showed its coronavirus vaccine was up to 90 per cent effective, giving public health officials hope they may... Mid-Day